{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:23:39Z","timestamp":1790166219129,"version":"4.1.0"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174107","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T15:57:54Z","timestamp":1489679874000},"page":"e0174107","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia"],"prefix":"10.1371","volume":"12","author":[{"given":"Muhammad","family":"Rauzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles T. H.","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun Kiat","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Tiong","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"BJ Druker","year":"2008","journal-title":"Blood"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"M Copland","year":"2006","journal-title":"Blood"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.2008.19.8853","article-title":"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR\/ABL mutants","volume":"27","author":"S Redaelli","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrclinonc.2009.112","article-title":"Imatinib and beyond[mdash]exploring the full potential of targeted therapy for CML","volume":"6","author":"A Quintas-Cardama","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"KP Ng","year":"2012","journal-title":"Nat Med"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"MF Fraga","year":"2005","journal-title":"Nat Genet"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.107.124461","article-title":"Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors","volume":"322","author":"SM Lee","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001622-200111000-00010","article-title":"Histone deacetylase inhibitors as new cancer drugs","volume":"13","author":"PA Marks","year":"2001","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1158\/0008-5472.CAN-12-3479","article-title":"EGFR-TKI Resistance Due to BIM Polymorphism Can Be Circumvented in Combination with HDAC Inhibition","volume":"73","author":"T Nakagawa","year":"2013","journal-title":"Cancer Research"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1535-7163.MCT-09-0689","article-title":"SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer","volume":"9","author":"V Novotny-Diermayr","year":"2010","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2867-13-32","article-title":"Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells","volume":"13","author":"S Okabe","year":"2013","journal-title":"Cancer Cell Int"},{"issue":"25","key":"ref12","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","article-title":"Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function","volume":"110","author":"S Lim","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/MCB.13.3.1728","article-title":"SH1 domain autophosphorylation of P210 BCR\/ABL is required for transformation but not growth factor independence","volume":"13","author":"AM Pendergast","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"2","key":"ref14","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"K Shuai","year":"1996","journal-title":"Oncogene"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.183.3.811","article-title":"Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl","volume":"183","author":"N Carlesso","year":"1996","journal-title":"J Exp Med"},{"issue":"29","key":"ref16","doi-asserted-by":"crossref","first-page":"26729","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors","volume":"280","author":"P Bali","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"BT Scroggins","year":"2007","journal-title":"Mol Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:09:11Z","timestamp":1540246151000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174107"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Maga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174107","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}